ArticleFrontiers in oncology2024

Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.

Darrell White et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.